Table 1

Description of Screening Technologies

Screening Technology
Test Performance (1)
Description

Simple Visual Screening
Sensitivity: 67–79%
Specificity: 49–86%
• Uses acetic acid to reveal acetowhite lesions
• For abnormal results, some advocate use with immediate cryotherapy – "see and treat" in a single visit
• Does not require special sample collection or laboratory processing equipment
• Low level health personnel can be trained to perform
• Personnel require supervision and retraining to maintain test performance
• Quality Assurance/Quality Control difficult to assess
• Generally requires 1–2 patient visits before treatment

Cervical Cytology
Sensitivity: 47–62%
Specificity: 60–95%
• Cervical smear taken and then sample prepared on slides or in liquid media for transport
• Because sample is generally examined in a laboratory, more than one patient visit may be required prior to treatment
• Sample collection equipment is minimal, but some laboratory equipment required
• Laboratory processing requires trained cytotechnicians and cytopathologists
• Human evaluation of samples requires supervision and retraining to maintain test performance
• Established Quality Assurance/Quality Control methods exist
• Generally requires 3 patient visits before treatment

HPV DNA Testing with Hybrid Capture 2
Sensitivity: 66–100%
Specificity: 61–96%
• Cervical sample taken and prepared for transport
• Because sample is generally tested in a laboratory, more than one patient visit may be required prior to treatment
• Sample collection kit and laboratory equipment required
• Laboratory processing is automated requiring fewer personnel resources with less training
• Results are quantitative in nature
• Established Quality Assurance/Quality Control methods exist
• Generally requires 2–3 patient visits before treatment

(1) Sankaranarayanan 2005

Goldhaber-Fiebert and Goldie Cost Effectiveness and Resource Allocation 2006 4:13   doi:10.1186/1478-7547-4-13

Open Data